Trial intelligence / Profile preview

NC1 (Autologous MSCs) in Chronic Spinal Cord Injury

NCT02570932Phase 2Completed

Sponsor
Hospital Universitario Puerta de Hierro Majadahonda
Start
Jul 2015
Primary completion
Dec 2017
Countries
1
01

Overview

A Phase 2 trial of autologous bone marrow stromal cells in spinal cord injury (SCI), sponsored by Hospital Universitario Puerta de Hierro Majadahonda. Started Jul 2015; status: completed.

02

Drugs

autologous bone marrow stromal cells
03

Conditions

spinal cord injury (SCI)

Beyond the preview

Go deeper on NCT02570932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02570932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call